🏥 Molybdenum-99 & Lutetium-177 Radiopharmaceuticals

Dedicated Medical Isotope Nuclear Reactor Model

Underwrite 20MWth dedicated low-enriched uranium (LEU) research reactors producing critical diagnostic & cancer therapeutic isotopes (Molybdenum-99/Tc-99m & Lutetium-177 for oncology clinics). Model radiopharma hospital contracts ($12,000/Curie), and 25-yr IRR.

1. Capacity & Unit Economics

Annual Mo-99 / Lu-177 Produced (Thousand Curies / Yr)

Hospital Radiopharmaceutical Price ($k / Curie)

Hot Cell Target Extraction & Shielding OpEx ($M / Yr)

LEU Pool Reactor & Cleanroom CapEx ($M)

2. Financial Returns & Yield

CLINICAL ONCOLOGY ISOTOPES

Annual Net EBITDA

$0 / yr

25-Yr Project IRR

0.0%

Gross Revenue

$0 / yr

Total CapEx

Annual OpEx

$0 / yr